|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from ICN Pharmaceuticals,
Inc.'s June 30, 2000 Consolidated Condensed Financial Statements and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C> <C>
<PERIOD-TYPE> 3-MOS 6-MOS
<FISCAL-YEAR-END> DEC-31-2000 DEC-31-2000
<PERIOD-START> APR-01-2000 JAN-01-2000
<PERIOD-END> JUN-30-2000 JUN-30-2000
<CASH> 188,808 188,808
<SECURITIES> 0 0
<RECEIVABLES> 247,140 247,140
<ALLOWANCES> (22,997) (22,997)
<INVENTORY> 139,161 139,161
<CURRENT-ASSETS> 569,684 569,684
<PP&E> 408,927 408,927
<DEPRECIATION> (88,248) (88,248)
<TOTAL-ASSETS> 1,472,748 1,472,748
<CURRENT-LIABILITIES> 120,710 120,710
<BONDS> 0 0
0 0
0 0
<COMMON> 791 791
<OTHER-SE> 718,343 718,343
<TOTAL-LIABILITY-AND-EQUITY> 1,472,748 1,472,748
<SALES> 148,331 307,671
<TOTAL-REVENUES> 191,433 383,773
<CGS> 60,935 121,701
<TOTAL-COSTS> 60,935 121,701
<OTHER-EXPENSES> 2,852 6,853
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 15,414 30,635
<INCOME-PRETAX> 33,617 72,065
<INCOME-TAX> 3,431 14,542
<INCOME-CONTINUING> 31,093 58,492
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> 31,093 58,492
<EPS-BASIC> .39 .74
<EPS-DILUTED> .38 .72
</TABLE>
|
|